Divergent effects of the purinoceptor antagonists suramin and pyridoxal-5'-phosphate-6-(2'-naphthylazo-6'-nitro-4',8'-disulfonate) (PPNDS) on alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors.
Suzuki
Erika
E
Department of Pharmacology, Southern Illinois University School of Medicine, Springfield, Illinois 62702, USA.
Kessler
Markus
M
Montgomery
Kyle
K
Arai
Amy C
AC
D000818:Animals; D001921:Brain / Q000502:physiology; D002460:Cell Line; D002462:Cell Membrane / Q000187:drug effects / Q000502:physiology; D006801:Humans; D007668:Kidney; D008564:Membrane Potentials / Q000187:drug effects / Q000502:physiology; D018408:Patch-Clamp Techniques; D058919:Purinergic P2 Receptor Antagonists; D011732:Pyridoxal Phosphate / Q000031:analogs & derivatives* / Q000494:pharmacology*; D051381:Rats; D018091:Receptors, AMPA / Q000187:drug effects / Q000502:physiology*; D013451:Sulfonic Acids / Q000494:pharmacology*; D013498:Suramin / Q000494:pharmacology*
D058919:Purinergic P2 Receptor Antagonists; D018091:Receptors, AMPA; D013451:Sulfonic Acids; C405633:pyridoxal-5'-phosphate-6-(2'-naphthylazo-6'-nitro-4',8'-disulfonate); D011732:Pyridoxal Phosphate; D013498:Suramin; C104722:glutamate receptor ionotropic, AMPA 2